Raphas Co., Ltd. Logo

Raphas Co., Ltd.

Develops dissolving microneedle patches for cosmetic, medical, and pharmaceutical applications.

214260 | KO

Overview

Corporate Details

ISIN(s):
KR7214260002
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로1길 62 라파스, 강서구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Raphas Co., Ltd. is a biotechnology company specializing in the research, development, and manufacturing of its proprietary transdermal delivery platform. The company's core technology is the patented Dissolving Microneedle (DEN), which enables the effective delivery of active ingredients for cosmetic, medical device, and pharmaceutical applications. Raphas develops and mass-produces innovative microarray patches, commercializing its technology through its own cosmetics brand, Acropass, as well as through partnerships. The platform offers solutions for skin care, including wrinkle and whitening treatments, and is being developed for the potential delivery of drugs and vaccines.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 2.0 MB
2025-08-14 00:00
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
Korean 2.0 MB
2025-07-28 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.9 KB
2025-06-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-06-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 127.7 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.0 MB
2025-04-28 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.5 KB
2025-03-26 00:00
AGM Information
정기주주총회결과
Korean 21.1 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-18 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 373.5 KB
2025-03-18 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 361.8 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 723.2 KB
2025-03-05 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 11.9 KB
2025-03-05 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 15.6 KB
2025-03-05 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 189.7 KB

Automate Your Workflow. Get a real-time feed of all Raphas Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Raphas Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Raphas Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

INOVIO PHARMACEUTICALS, INC. Logo
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
United States of America
INO
INSMED Inc Logo
Develops and commercializes innovative therapies for serious and rare diseases.
United States of America
INSM
Instil Bio, Inc. Logo
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
United States of America
TIL
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America
INTS
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel
INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden
IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea
048530
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
Inventiva S.A. Logo
Develops oral small molecule therapies for NASH, fibrosis, and rare metabolic disorders.
United States of America
IVA
Invivyd, Inc. Logo
Develops evolution-resistant antibodies to protect against viral diseases like COVID-19 and flu.
United States of America
IVVD

Talk to a Data Expert

Have a question? We'll get back to you promptly.